Previous studies have shown evidence of constitutive and cytokine-inducible
nitric oxide (NO) synthase activity in cultured osteoblast-like cells from
various species. Although cytokine-induced NO production has been found to
inhibit osteoblast growth, the role of constitutive NO production in regul
ating osteoblast function is less clear and the isoforms of nitric oxide sy
nthase (NOS) that are expressed by human osteoblasts have not been determin
ed. Here, we investigated NOS expression in cultured human osteoblast-like
cells and studied the effects of constitutive and cytokine-induced NO on os
teoblast growth and differentiation. Low levels of NO were produced constit
utively by osteoblast-like cells as reflected by analysis of medium nitrite
concentrations, and evidence of ecNOS mRNA, protein, and bioactivity was f
ound in primary osteoblasts (hOBs), TE85, and MG63 osteosarcoma cells. None
of the osteoblast-like cells expressed nNOS, however, and iNOS was produce
d only by hOB cells after stimulation with the cytokines IL-1 beta, TNF-alp
ha, and IFN-gamma, The NOS inhibitor, L-NMMA, did not affect growth or alka
line phosphatase activity in unstimulated osteoblasts, Incubation of hOB ce
lls with cytokines inhibited growth and stimulated alkaline phosphatase act
ivity and these effects were abrogated by L-NMMA, Cytokines also inhibited
growth of TE85 cells and MG63 cells, but these effects appeared to be NO in
dependent because they were not influenced by L-NMMA, Our experiments show
that human osteoblasts constitutively produce NO through the ecNOS pathway,
but demonstrate that this does not appear to exert an appreciable effect o
n osteoblast growth or differentiation under basal conditions. In contrast,
IL-1 beta, TNF-alpha, and IFN-gamma exerted growth-inhibiting and differen
tiation-inducing effects on osteoblasts that were partly NO dependent, indi
cating that NO may act predominantly as a modulator of cytokine-induced eff
ects on osteoblast function, (Bone 24: 179-185; 1999) (C) 1999 by Elsevier
Science Inc. All rights reserved.